Patients Benefit from Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria without Harming the Health Care System

SIMPLE SUMMARY: Liver transplantation (LT) is the only definitive treatment to cure hepatocellular carcinoma (HCC) in cirrhosis. Unfortunately, the shortage of donor livers limits access to the best available therapy. As a consequence, transplant candidates undergo selection for transparent waiting...

Descripción completa

Detalles Bibliográficos
Autores principales: Gundlach, Jan-Paul, Linecker, Michael, Dobbermann, Henrike, Wadle, Felix, Becker, Thomas, Braun, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909584/
https://www.ncbi.nlm.nih.gov/pubmed/35267443
http://dx.doi.org/10.3390/cancers14051136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909584/
https://www.ncbi.nlm.nih.gov/pubmed/35267443
http://dx.doi.org/10.3390/cancers14051136

Ejemplares similares